Pfizer asks FDA to authorize Covid booster shots for all adults
Germaine T. Leftwich, 67, receives a Pfizer covid-19 vaccine booster shot from Dr. Tiffany Taliaferro at the Safeway on Capitol Hill in Washington, D.C., on Monday, October 4, 2021.
Tom Williams | CQ-Roll Call, Inc. | Getty Images
Pfizer said Tuesday it asked the Food and Drug Administration to authorize booster shots of its Covid-19 vaccine for all Americans age 18 and older, a move that would significantly increase the number of people eligible to get the extra shots.
A third dose of the vaccine, which was developed with German partner BioNTech, has already been authorized by the FDA for elderly people and at-risk adults six months after they complete their primary series of shots.
Booster shots of Moderna’s vaccine have also been cleared for the same groups as Pfizer’s while a second shot of Johnson & Johnson’s has already been cleared for all adults. More than 25 million Americans have received an additional dose of one of the three vaccines as of Monday, according to data compiled the Centers for Disease Control and Prevention.
Pfizer said Tuesday it is asking the agency to amend its authorization after data based on more than 10,000 individuals shows an additional dose is safe and effective in all adults.
The FDA could grant Pfizer’s request before Thanksgiving, the New York Times reported, citing unnamed sources.
Booster shots have been a contentious topic for scientists — in and outside the government — especially as many people in the U.S. and other parts of the world have yet to receive even one dose of a vaccine. The World Health Organization is urging wealthy countries to hold off on distributing boosters. Some scientists say they aren’t convinced most Americans need boosters right now.
President Joe Biden in August said he wanted to roll out boosters shots to all adults as early as September. However, an influential FDA advisory committee later rejected that proposal, paring back those plans to unanimously recommend the third shots to people age 65 and older and other vulnerable Americans.